The Aging of America Could Make HCA Healthcare a Long-Term Winner

Core Insights - HCA Healthcare demonstrates strong earnings growth and volume gains, with adjusted EBITDA increasing, indicating solid fundamentals despite missing analyst revenue estimates last quarter [2][4] - The company's guidance for 2026 suggests potential for growth in various areas, although challenges remain [2] - HCA's stock may appeal to long-term investors due to anticipated healthcare demand trends, despite limited short-term growth potential [2][3] Financial Performance - In Q4 2025, HCA reported earnings per share (EPS) of $8.01, exceeding analyst expectations of $7.37, marking a nearly 29% improvement [4][5] - Revenue growth was 6.7% year-over-year, but fell short of the forecasted $19.7 billion by approximately $158 million [5][6] - The company achieved its 19th consecutive quarter of volume growth, with adjusted EBITDA rising by 11% year-over-year and an improvement in adjusted EBITDA margin by 80 basis points [6]